Customer Service: 866-788-9007
×

SKIN
CANCER
CONNECT

The latest news in cutaneous melanoma
and squamous cell carcinoma.

JANUARY 2023

Copy-of-Holiday-Card-2021-600-×-200-px

HAPPY NEW YEAR FROM CASTLE BIOSCIENCES

In the new year, we find ourselves reflecting on 2022 and those who have utilized our testing for their patients. It was quite a year at Castle Biosciences, with more than 37,000 dermatology test reports delivered in 2022, designed to impact the lives of the patients you serve. We hope that 2022 has been just as memorable for you, your colleagues, and your loved ones. We look forward to working with you in 2023.

B5_31VE_0_COCKERELL_109381
WEBINAR

DermPath on Demand: Utility of Gene Expression Profiling in Melanocytic Lesions

This special edition of "Dermpath on Demand" focuses on Castle Biosciences' gene expression profile (GEP) tests for the diagnosis and management of melanoma. Clay Cockerell, M.D. reviews several cases in which GEP testing aided in the diagnosis and management of patients with melanocytic lesions.

 

Picture5
CASE STUDY OF THE MONTH

Abnormally Pigmented Lesion with Uncertain Malignant Potential

A woman in her 30’s presents to her dermatologist for evaluation of an isolated lesion with irregular pigmentation on her inner thigh. When evaluated by dermoscopy the lesion showed a global disorganized pattern including focal pseudopods and a central eccentric dark structureless area. Reflectance confocal microscopy showed dendritic and pagetoid cells in the epidermis.

Side view of a senior man sitting in a park taking a break after fitness workout. Fitness person relaxing in park drinking water and thinking.
RESEARCH & DEVELOPMENT

New SCC Data Now Published in SKIN

Data recently presented at the Annual Fall Clinical Dermatology Conference® is now available in SKIN, The Journal of Cutaneous Medicine. This publication highlights the positive clinical impact DecisionDx-SCC (40-GEP) is having on clinicians’ assessment of risk for their +65-year-old, high-risk cSCC patients with a clinical actionability rate that is similar to other gene expression profile tests used in solid tumors.

Beautiful sunset at a beach resort in tropics with palms

UPCOMING EVENTS

Winter Clinical Dermatology Conference - Hawaii

  • January 13-18
  • Kohala Coast, HI

Melanoma 2023: 33rd Annual Cutaneous Malignancy Update

  • January 20-22
  • San Diego, CA

Maui Derm Hawaii 2023

  • January 23-27
  • Maui, HI

NRG Oncology Winter Meeting

  • January 26-28
  • Orlando, FL

18th Annual Academic Surgical Congress

  • February 7-9
  • Houston, TX

Dermatology Nurses Association - 41st Annual Convention

  • February 7-9
  • Savannah, GA

South Beach Symposium

  • February 9-12
  • Miami, FL

Winter Clinical Miami

  • February 17-19
  • Miami, FL

 

 

NOT REGISTERED?
NO PROBLEM!

Sign up for access to our monthly newsletter online
and directly in your inbox each month.

Scroll to Top
Scroll to Top